Airsculpt Technologies is trading 5% down at $4.42, extending its recent downside momentum as investors rotate out of smaller healthcare names.
- The stock is notably underperforming a broader rally in the healthcare sector, with investors favoring larger and more liquid peers.
- The decline appears driven by general risk-off sentiment and Fed-related macro uncertainty rather than any stock-specific news or fundamental catalysts.
- Shares continue to face pressure as market participants avoid smaller-cap equities during periods of increased market volatility.